Bioage Labs Inc (BIOA)
19.45
-0.72
(-3.57%)
USD |
NASDAQ |
Nov 14, 16:00
20.43
+0.98
(+5.04%)
After-Hours: 20:00
Bioage Labs EPS Diluted (Quarterly): -0.4393 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.4393 |
| March 31, 2024 | -0.4203 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.556 |
| March 31, 2023 | -0.3586 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.556
Minimum
Jun 2023
-0.3586
Maximum
Mar 2023
-0.4436
Average
-0.4298
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly and Co | 1.07 |
| Perspective Therapeutics Inc | -0.18 |
| Electromed Inc | 0.20 |
| Xtant Medical Holdings Inc | -0.03 |
| Myomo Inc | -0.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.58M |
| Total Expenses (Quarterly) | 15.27M |
| Enterprise Value | 475.77M |
| Earnings Yield | -9.12% |